Karen Sánchez Trejo
Research Subjects
Research Interests
Karen Sánchez Trejo has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Eduardo Soei Sarmiento Sánchez
Centro Médico Nacional 20 de Noviembre, Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado, Av. Felix Cuevas #540 Col, Del Valle Del, Benito Juárez CP 03100, México, D.F Mexico City, Mexico
1 shared publication - Herman Soto Molina
Departamento de Evaluación Económica, Agencia Mexicana de Evaluación de Tecnologías Sanitarias AC, Cerrada Gavilán #68 int 2 Col Barrio San Miguel, Iztapalapa, CP 09360, Mexico City, Mexico
1 shared publication - Humberto García Aguilar
Servicio de Cardiología Pediátrica, Centro Médico 20 de Noviembre, México, Mexico City, Mexico, Mexico
1 shared publication - Katiria Itzel Juárez Vásquez
Departamento de Evaluación Económica, Agencia Mexicana de Evaluación de Tecnologías Sanitarias AC, Cerrada Gavilán #68 int 2 Col Barrio San Miguel, Iztapalapa, CP 09360, Mexico City, Mexico
1 shared publication - Silvia Guzmán Vázquez
Departamento de Evaluación Económica, Agencia Mexicana de Evaluación de Tecnologías Sanitarias AC, Cerrada Gavilán #68 int 2 Col Barrio San Miguel, Iztapalapa, CP 09360, Mexico City, Mexico
1 shared publication - Yazmin Escobar Juárez
Departamento de Evaluación Económica, Agencia Mexicana de Evaluación de Tecnologías Sanitarias AC, Cerrada Gavilán #68 int 2 Col Barrio San Miguel, Iztapalapa, CP 09360, Mexico City, Mexico
1 shared publication
Latest Publications
- 1 November 2021
- Published by Becaris Publishing Limited in Journal of Comparative Effectiveness Research
- Vol. 10 (16) , 1251-1257
Healthcare resource utilization and costs in pediatric pulmonary arterial hypertension in a third-level hospital in Mexico
Aim: The objective of this study was to evaluate the healthcare costs and resource utilization of pediatric pulmonary arterial hypertension management at a third-level hospital in Mexico. Methods: A retrospective cohort study was conducted in a pediatric population with pulmonary arterial hypertension. Only direct medical costs, derived from pharmacological treatment, laboratory tests, physician visits and hospitalizations, were considered. From an institutional perspective, all costs were accounted for in 2019 US dollars. Results: A total of 82 patients were included. Of these, 55% were female and the mean age was 6.9 (standard deviation ± 4) years. The mean annual cost was $17,452.14 (standard deviation ± $38,944.10), with a median cost of $8832.75. Conclusion: Pulmonary arterial hypertension is a costly disease, with hospitalization and pharmacological treatment being areas with a higher economic burden. Functional class IV has greater resource utilization and costs.
- 1 November 2021
- Published by Becaris Publishing Limited in Journal of Comparative Effectiveness Research
- Vol. 10 (16) , 1251-1257
Healthcare resource utilization and costs in pediatric pulmonary arterial hypertension in a third-level hospital in Mexico
Aim: The objective of this study was to evaluate the healthcare costs and resource utilization of pediatric pulmonary arterial hypertension management at a third-level hospital in Mexico. Methods: A retrospective cohort study was conducted in a pediatric population with pulmonary arterial hypertension. Only direct medical costs, derived from pharmacological treatment, laboratory tests, physician visits and hospitalizations, were considered. From an institutional perspective, all costs were accounted for in 2019 US dollars. Results: A total of 82 patients were included. Of these, 55% were female and the mean age was 6.9 (standard deviation ± 4) years. The mean annual cost was $17,452.14 (standard deviation ± $38,944.10), with a median cost of $8832.75. Conclusion: Pulmonary arterial hypertension is a costly disease, with hospitalization and pharmacological treatment being areas with a higher economic burden. Functional class IV has greater resource utilization and costs.